Clinical Trial Update: Tariquidar-ondansetron Combination in Neuropathic Pain [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial results are reported for the Tariquidar-ondansetron combination in neuropathic pain. The study status is completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Drugs mentioned

• Ondansetron (ondansetron)
• Tariquidar (tariquidar)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Neuropathic Pain | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-08-14